Skip to main content
Top
Published in: Clinical Rheumatology 8/2020

01-08-2020 | COVID-19 | Letter to the Editor

COVID-19 and Kawasaki disease: an analysis using Google Trends

Authors: Mrinalini Dey, Sizheng Steven Zhao

Published in: Clinical Rheumatology | Issue 8/2020

Login to get access

Excerpt

COVID-19, a novel coronavirus disease, was declared a pandemic by the World Health Organisation on 11 March 2020. There have been 4,248,389 confirmed cases and 294,046 fatalities worldwide [1]. COVID-19 has been reported in children, although comprising < 2% of cases (https://​www.​rcpch.​ac.​uk/​sites/​default/​files/​generated-pdf/​document/​COVID-19%2D%2D-research-evidence-summaries.​pdf). Paediatric COVID-19 generally follows a milder course. However, there have been reports of a “Kawasaki-like” syndrome in children, first published in April 2020 [2]. This was followed by a case series in London, describing Kawasaki-like shock in children with COVID-19 [3], and reports of clusters in countries including Spain, Italy, and the USA [2]. …
Literature
2.
go back to reference Jones VG, Mills M, Suarez D, Hogan CA, Yeh D, Bradley Segal J et al (2020) COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr 7 Jones VG, Mills M, Suarez D, Hogan CA, Yeh D, Bradley Segal J et al (2020) COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr 7
4.
go back to reference Soni PR, Noval Rivas M, Arditi M. A comprehensive update on Kawasaki disease vasculitis and myocarditis. Vol. 22, Current Rheumatology Reports. Springer; 2020. p. 1–11 Soni PR, Noval Rivas M, Arditi M. A comprehensive update on Kawasaki disease vasculitis and myocarditis. Vol. 22, Current Rheumatology Reports. Springer; 2020. p. 1–11
Metadata
Title
COVID-19 and Kawasaki disease: an analysis using Google Trends
Authors
Mrinalini Dey
Sizheng Steven Zhao
Publication date
01-08-2020
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 8/2020
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05231-z

Other articles of this Issue 8/2020

Clinical Rheumatology 8/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.